# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-19-244158
Filing Date
2019-09-13
Accepted
2019-09-12 19:46:40
Documents
40
Period of Report
2019-09-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d802454d8k.htm | 8-K | 19386
2 | EX-99.1 | d802454dex991.htm | EX-99.1 | 26566
3 | GRAPHIC | g802454ex99_1s10g1.jpg | GRAPHIC | 149732
4 | GRAPHIC | g802454ex99_1s11g1.jpg | GRAPHIC | 160789
5 | GRAPHIC | g802454ex99_1s12g1.jpg | GRAPHIC | 192384
6 | GRAPHIC | g802454ex99_1s13g1.jpg | GRAPHIC | 148244
7 | GRAPHIC | g802454ex99_1s14g1.jpg | GRAPHIC | 225023
8 | GRAPHIC | g802454ex99_1s15g1.jpg | GRAPHIC | 184972
9 | GRAPHIC | g802454ex99_1s16g1.jpg | GRAPHIC | 187243
10 | GRAPHIC | g802454ex99_1s17g1.jpg | GRAPHIC | 201611
11 | GRAPHIC | g802454ex99_1s18g1.jpg | GRAPHIC | 175131
12 | GRAPHIC | g802454ex99_1s19g1.jpg | GRAPHIC | 246465
13 | GRAPHIC | g802454ex99_1s1g1.jpg | GRAPHIC | 222321
14 | GRAPHIC | g802454ex99_1s20g1.jpg | GRAPHIC | 107016
15 | GRAPHIC | g802454ex99_1s21g1.jpg | GRAPHIC | 185566
16 | GRAPHIC | g802454ex99_1s22g1.jpg | GRAPHIC | 192069
17 | GRAPHIC | g802454ex99_1s23g1.jpg | GRAPHIC | 148089
18 | GRAPHIC | g802454ex99_1s24g1.jpg | GRAPHIC | 224880
19 | GRAPHIC | g802454ex99_1s25g1.jpg | GRAPHIC | 177995
20 | GRAPHIC | g802454ex99_1s26g1.jpg | GRAPHIC | 201509
21 | GRAPHIC | g802454ex99_1s27g1.jpg | GRAPHIC | 116607
22 | GRAPHIC | g802454ex99_1s28g1.jpg | GRAPHIC | 124683
23 | GRAPHIC | g802454ex99_1s29g1.jpg | GRAPHIC | 180376
24 | GRAPHIC | g802454ex99_1s2g1.jpg | GRAPHIC | 185720
25 | GRAPHIC | g802454ex99_1s30g1.jpg | GRAPHIC | 184563
26 | GRAPHIC | g802454ex99_1s31g1.jpg | GRAPHIC | 121526
27 | GRAPHIC | g802454ex99_1s32g1.jpg | GRAPHIC | 234062
28 | GRAPHIC | g802454ex99_1s33g1.jpg | GRAPHIC | 121527
29 | GRAPHIC | g802454ex99_1s34g1.jpg | GRAPHIC | 159105
30 | GRAPHIC | g802454ex99_1s35g1.jpg | GRAPHIC | 107545
31 | GRAPHIC | g802454ex99_1s36g1.jpg | GRAPHIC | 112948
32 | GRAPHIC | g802454ex99_1s37g1.jpg | GRAPHIC | 90858
33 | GRAPHIC | g802454ex99_1s38g1.jpg | GRAPHIC | 175145
34 | GRAPHIC | g802454ex99_1s3g1.jpg | GRAPHIC | 174052
35 | GRAPHIC | g802454ex99_1s4g1.jpg | GRAPHIC | 185186
36 | GRAPHIC | g802454ex99_1s5g1.jpg | GRAPHIC | 180239
37 | GRAPHIC | g802454ex99_1s6g1.jpg | GRAPHIC | 124459
38 | GRAPHIC | g802454ex99_1s7g1.jpg | GRAPHIC | 187933
39 | GRAPHIC | g802454ex99_1s8g1.jpg | GRAPHIC | 160045
40 | GRAPHIC | g802454ex99_1s9g1.jpg | GRAPHIC | 164254
| Complete submission text file | 0001193125-19-244158.txt |  | 8897046

Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 191091358
SIC: 2835 In Vitro & In Vivo Diagnostic Substances